Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel

Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel: Two Case Reports

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel : Two Case Reports. / Baglama, Špela Šuler; Trajber Horvat, Anja; Peteln, Irena; Jemec, Gregor Borut Ernst.

I: Case Reports in Dermatology, Bind 14, Nr. 3, 2022, s. 362-367.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Baglama, ŠŠ, Trajber Horvat, A, Peteln, I & Jemec, GBE 2022, 'Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel: Two Case Reports', Case Reports in Dermatology, bind 14, nr. 3, s. 362-367. https://doi.org/10.1159/000528128

APA

Baglama, Š. Š., Trajber Horvat, A., Peteln, I., & Jemec, G. B. E. (2022). Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel: Two Case Reports. Case Reports in Dermatology, 14(3), 362-367. https://doi.org/10.1159/000528128

Vancouver

Baglama ŠŠ, Trajber Horvat A, Peteln I, Jemec GBE. Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel: Two Case Reports. Case Reports in Dermatology. 2022;14(3):362-367. https://doi.org/10.1159/000528128

Author

Baglama, Špela Šuler ; Trajber Horvat, Anja ; Peteln, Irena ; Jemec, Gregor Borut Ernst. / Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel : Two Case Reports. I: Case Reports in Dermatology. 2022 ; Bind 14, Nr. 3. s. 362-367.

Bibtex

@article{2706e8bee25a492b98e167ed060a0292,

title = "Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel: Two Case Reports",

abstract = "The observations of a beneficial effect of 5-fluorouracil-induced actinic keratoses (AK) inflammation led to the development of topical fluorouracil, a product registered for the management of AK. A conscientious surveillance of AK inflammation during chemotherapy may conceivably lead to the development of further drugs for treatment of AK. A number of other chemotherapeutics have thus been linked to similar reactions without ensuing development. Here, we describe two further cases linking chemotherapy with carboplatin and paclitaxel to possible anti-AK effects, identifying them as potential treatments. Whether multidrug chemotherapy leads to stronger AK inflammation or cure AK more successfully is currently unknown.",

keywords = "Actinic keratoses, Carboplatin, Chemotherapy, Inflammation, Paclitaxel",

author = "Baglama, {{\v S}pela {\v S}uler} and {Trajber Horvat}, Anja and Irena Peteln and Jemec, {Gregor Borut Ernst}",

year = "2022",

doi = "10.1159/000528128",

language = "English",

volume = "14",

pages = "362--367",

journal = "Case Reports in Dermatology",

issn = "1662-6567",

publisher = "S Karger AG",

number = "3",

}

RIS

TY - JOUR

T1 - Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel

T2 - Two Case Reports

AU - Baglama, Špela Šuler

AU - Trajber Horvat, Anja

AU - Peteln, Irena

AU - Jemec, Gregor Borut Ernst

PY - 2022

Y1 - 2022

N2 - The observations of a beneficial effect of 5-fluorouracil-induced actinic keratoses (AK) inflammation led to the development of topical fluorouracil, a product registered for the management of AK. A conscientious surveillance of AK inflammation during chemotherapy may conceivably lead to the development of further drugs for treatment of AK. A number of other chemotherapeutics have thus been linked to similar reactions without ensuing development. Here, we describe two further cases linking chemotherapy with carboplatin and paclitaxel to possible anti-AK effects, identifying them as potential treatments. Whether multidrug chemotherapy leads to stronger AK inflammation or cure AK more successfully is currently unknown.

AB - The observations of a beneficial effect of 5-fluorouracil-induced actinic keratoses (AK) inflammation led to the development of topical fluorouracil, a product registered for the management of AK. A conscientious surveillance of AK inflammation during chemotherapy may conceivably lead to the development of further drugs for treatment of AK. A number of other chemotherapeutics have thus been linked to similar reactions without ensuing development. Here, we describe two further cases linking chemotherapy with carboplatin and paclitaxel to possible anti-AK effects, identifying them as potential treatments. Whether multidrug chemotherapy leads to stronger AK inflammation or cure AK more successfully is currently unknown.

KW - Actinic keratoses

KW - Carboplatin

KW - Chemotherapy

KW - Inflammation

KW - Paclitaxel

U2 - 10.1159/000528128

DO - 10.1159/000528128

M3 - Journal article

C2 - 36655062

AN - SCOPUS:85144206258

VL - 14

SP - 362

EP - 367

JO - Case Reports in Dermatology

JF - Case Reports in Dermatology

SN - 1662-6567

IS - 3

ER -

ID: 335697607